Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Thursday, 9th May 2024 AVXL stock ended at $3.88. This is 4.58% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.32% from a day low at $3.60 to a day high of $3.93.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
May 31, 2016 $4.41 $4.49 $4.36 $4.44 199 580
May 27, 2016 $4.41 $4.47 $4.28 $4.46 292 037
May 26, 2016 $4.44 $4.48 $4.36 $4.43 217 634
May 25, 2016 $4.45 $4.50 $4.35 $4.45 261 217
May 24, 2016 $4.48 $4.49 $4.36 $4.41 282 296
May 23, 2016 $4.51 $4.55 $4.29 $4.48 457 101
May 20, 2016 $4.30 $4.59 $4.18 $4.43 850 153
May 19, 2016 $4.05 $4.17 $3.92 $4.15 322 183
May 18, 2016 $4.13 $4.25 $4.00 $4.09 427 726
May 17, 2016 $4.02 $4.17 $3.87 $4.05 494 776
May 16, 2016 $3.99 $4.09 $3.96 $4.00 295 917
May 13, 2016 $4.00 $4.19 $4.00 $4.05 397 825
May 12, 2016 $4.33 $4.47 $3.88 $4.00 1 035 799
May 11, 2016 $4.47 $4.67 $4.28 $4.39 343 991
May 10, 2016 $4.26 $4.67 $4.25 $4.49 626 475
May 09, 2016 $4.75 $4.79 $4.20 $4.20 1 134 181
May 06, 2016 $5.10 $5.13 $4.76 $4.81 648 638
May 05, 2016 $5.20 $5.28 $5.12 $5.19 282 558
May 04, 2016 $5.45 $5.48 $5.12 $5.20 410 362
May 03, 2016 $5.15 $5.53 $5.12 $5.50 564 743
May 02, 2016 $5.39 $5.54 $5.06 $5.24 1 491 698
Apr 29, 2016 $5.58 $5.60 $5.35 $5.46 665 842
Apr 28, 2016 $5.59 $5.70 $5.50 $5.56 565 143
Apr 27, 2016 $5.90 $5.99 $5.58 $5.66 932 250
Apr 26, 2016 $6.01 $6.10 $5.70 $5.90 1 663 916
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT